VHT – Morgans rates the stock as Add

Morgans believes there is value (unrecognised by the market) in Volpara Health Technologies’ data set (51m images) that could be worth up to $100m. The broker adopts a changed valuation method and raises its target price to $1.94 from $1.87. Add retained.

Via a recent newsletter, the analyst notes management declared the 3Q22 has been strong and will beat the previous best 3Q in terms of new annual recurring revenue (ARR).

Sector: Health Care Equipment & Services.


Target price is $1.94.Current Price is $0.91. Difference: $1.03 – (brackets indicate current price is over target). If VHT meets the Morgans target it will return approximately 100% (excluding dividends, fees and charges – negative figures indicate an expected loss).



About Broker News

FNArena's Australian Broker Call, is your daily news report on the latest recommendation, valuation, forecast and opinions recently published by Stockbrokers.

View more articles by Broker News →